1. A170 ADVERSE EVENTS & SEROLOGICAL RESPONSES FOLLOWING SARS-COV-2 VACCINATION IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE. (7th March 2023) Authors: Markovinovic, A; Herauf, M; Quan, J; Hracs, L; Windsor, J W; Sharifi, N; Coward, S; Caplan, L; Gorospe, J; Ma, C; Panaccione, R; Ingram, R; Kanji, J; Tipples, G; Holodinsky, J; Berstein, C; Mahoney, D; Bernatsky, S; Benchimol, E; Kaplan, G G Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 6(2023)Supplement 1 Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A195 DURABILITY OF SEROLOGICAL RESPONSES AFTER SECOND, THIRD AND FOURTH DOSE OF SARS-COV-2 VACCINATION IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY. (7th March 2023) Authors: Sharifi, N; Ma, C; Seow, C; Quan, J; Hracs, L; Caplan, L; Markovinović, A; Herauf, M; Windsor, J; Coward, S; Buie, M; Gorospe, J; Panaccione, R; Kaplan, G Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 6(2023)Supplement 1 Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗